IMC Chicago
CRSP icon

IMC Chicago’s CRISPR Therapeutics CRSP Stock Holding History

IMC Chicago’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12M Buy
251,900
+53,900
+27% +$2.84M ﹤0.01% 1142
2025
Q4 		$10.4M Sell
198,000
-68,700
-26% -$4.11M ﹤0.01% 1191
2025
Q3 		$17.3M Sell
266,700
-42,800
-14% -$2.46M 0.01% 847
2025
Q2 		$15.1M Buy
309,500
+140,500
+83% +$5.44M 0.01% 824
2025
Q1 		$5.75M Buy
169,000
+8,200
+5% +$348K ﹤0.01% 1164
2024
Q4 		$6.33M Buy
160,800
+71,000
+79% +$3.35M ﹤0.01% 1122
2024
Q3 		$4.22M Buy
89,800
+11,300
+14% +$573K ﹤0.01% 1210
2024
Q2 		$4.24M Sell
78,500
-29,000
-27% -$1.68M ﹤0.01% 1139
2024
Q1 		$7.33M Sell
107,500
-27,300
-20% -$1.95M ﹤0.01% 824
2023
Q4 		$8.44M Buy
134,800
+39,000
+41% +$2.16M 0.01% 709
2023
Q3 		$4.35M Sell
95,800
-16,600
-15% -$857K ﹤0.01% 774
2023
Q2 		$6.31M Buy
112,400
+24,300
+28% +$1.38M 0.01% 616
2023
Q1 		$3.98M Buy
88,100
+23,400
+36% +$1.14M ﹤0.01% 683
2022
Q4 		$2.63M Sell
64,700
-24,100
-27% -$1.28M ﹤0.01% 751
2022
Q3 		$5.8M Sell
88,800
-26,600
-23% -$1.93M 0.01% 541
2022
Q2 		$7.01M Buy
115,400
+24,000
+26% +$1.41M 0.01% 499
2022
Q1 		$5.74M Sell
91,400
-19,000
-17% -$1.19M 0.01% 549
2021
Q4 		$8.37M Buy
110,400
+21,100
+24% +$1.84M 0.01% 517
2021
Q3 		$9.99M Buy
89,300
+500
+0.6% +$62.8K 0.01% 488
2021
Q2 		$14.4M Buy
88,800
+9,300
+12% +$1.13M 0.02% 390
2021
Q1 		$9.69M Buy
+79,500
New +$12M 0.01% 432

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IMC Chicago's CRSP Position: Q3 2025 in Review

IMC Chicago sold out of CRISPR Therapeutics (CRSP) in Q3 2025, closing a stake of 23,080 shares — an estimated $1.33M sold.

IMC Chicago first reported a position in CRSP in Q1 2021 and held it in 14 quarters. The position peaked at $3.49M in Q4 2021. 440 funds tracked by Wall St. Rank hold CRSP as of Q3 2025.

  • IMC Chicago reported no remaining CRISPR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • IMC Chicago sold 23,080 CRISPR Therapeutics shares in Q3 2025, an estimated $1.33M.
  • IMC Chicago first reported a position in CRISPR Therapeutics in Q1 2021 and held it in 14 quarters.
  • IMC Chicago's CRISPR Therapeutics position peaked at $3.49M in Q4 2021.
  • 440 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.